Diagnoses of gastrointestinal cancers after gastrointestinal bleeding in patients receiving clopidogrel or warfarin

Current Clinical Pharmacology

Volumn 8, Issue 4, 2013, Pages 261-269

  Asiimwe, Alex ^a   Li, Jian J ^a   Weerakkody, Govinda ^a   Vangerow, Harald ^a   Delisle, Frank ^a   Benoit, Karin ^a   Heath, Lori ^a   Wernicke, Joachim ^a   Motsko, Stephen ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Adverse effects; Database analysis; Detection bias; Epidemiology; Gastrointestinal bleeding; Neoplasms

Indexed keywords

CLOPIDOGREL; WARFARIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NITRATE; PRASUGREL; PROTON PUMP INHIBITOR; THIAZIDE DIURETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; BILLING AND CLAIMS; CANCER DIAGNOSIS; CANCER RISK; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DYSLIPIDEMIA; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PANCREAS CANCER; PEPTIC ULCER; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SMALL INTESTINE CANCER; STOMACH CANCER; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; YOUNG ADULT; CALCULATION; CONFIDENCE INTERVAL; DATA ANALYSIS SOFTWARE; DATA BASE; HAZARD RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; WARFARIN; YOUNG ADULT;

EID: 84888100742     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/15748863113089990048     Document Type: Article

References (15)

1. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50(7): e1-e157.
2. Cryer B. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies. N Engl J Med 2005; 352(3): 287-289.
3. Muller AD, Sonnenberg A, Wasserman IH. Diseases preceding colon cancer. A case-control study among veterans. Dig Dis Sci 1994; 39(11): 2480-2484.
4. Wysota BA, Gorard DA. Colonic carcinoma unmasked by dual antiplatelet therapy. Eur J Intern Med 2008; 19(7): 558-558.
5. Hansen LG, Chang S. Health research data for the real world: The Thomson Reuters MarketScan databases. MarketScan White Paper. 2012. Available from: http://www. truvenhealth. com/assets/2012_Truven_MarketScan_white_paper. pdf.
6. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375(9726): 1624-1633.
7. Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010; 56(24): 2051-2066.
8. McCall KL, MacLaughlin EJ. Warfarin-associated bleeding complication saved life. Pharmacotherapy 2002; 22(2): 265-268.
9. Norton SA, Armstrong CP. Lower gastrointestinal bleeding during anticoagulant therapy: a life-saving complication? Ann R Coll Surg Engl 1997; 79(1): 38-39.
10. Carey RJ. Warfarin-induced rectal bleeding as clue to colon cancer. Lancet 1984; 1(8375): 505-506.
11. Bini EJ, Rajapaksa RC, Weinshel EH. Positive predictive value of fecal occult blood testing in persons taking warfarin. Am J Gastroenterol 2005; 100(7): 1586-1592.
12. Symeonidis D, Koukoulis G, Christodoulidis G, Mamaloudis I, Chatzinikolaou I, Tepetes K. Impact of antiplatelet treatment on colorectal cancer staging characteristics. World J Gastrointest Endosc 2012; 4(9): 409-413.
13. Johannsdottir GA, Onundarson PT, Gudmundsdottir BR, Bjornsson ES. Screening for anemia in patients on warfarin facilitates diagnosis of gastrointestinal malignancies and pre-malignant lesions. Thromb Res 2012; 130(3): e20-e25.
14. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357(20): 2001-2015.
15. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61(4): 212-236.